[Ip-health] 2001 NGO statement calling for new global Convention on research & development

Jamie Love james.love at keionline.org
Fri Aug 31 08:21:07 PDT 2012

This is an NGO statement from the 2001 Hosbjor, Norway meeting.  Among
other things, it called for a "new global Convention on research &


Joint Statement of Consumer Project on Technology (CPT), Health Action
International (HAI), Medecins sans Frontieres (MSF), Oxfam and
Treatment Action Group (TAG) on the WTO / WHO on Differential Pricing
& Financing of Essential Drugs
April 11, 2001

HOSBJOR, Norway - Representatives of the five non-governmental
organizations (NGOs) who participated in the three day WHO / WTO
Workshop on Differential Pricing & Financing of Essential Drugs issued
the following joint statement on the goals, proceedings, and outcome
of the workshop.


Research & Development

The NGOs called for a new global Convention on research & development,
designed to strengthen both public- and private-sector research. At
every gathering to discuss access to medicines, the big pharma
companies raise the specter that any effort to help the poor will harm
R&D. Some claim proposals to lower drug prices in developing
countries, including the use of compulsory licensing of patents on
essential medicines, may lower their profits. The idea of the
Convention is to create new mechanism to boost global R&D funding in
ways consistent with access to medicines and health needs by
encouraging research on neglected diseases. Country support for R&D
funding could take a variety of forms, including publicly funded R&D,
mandatory R&D requirements for companies, or the big pharma solution,
which is high levels of patent protection and high prices.

The NGOs will ask the World Health Assembly in May to request the WHO
to convene the negotiations by the end of the year.

The NGOs noted with interest the proposal by Jeffrey Sachs of Harvard
University, who addressed the workshop by video uplink, for a global
infectious disease prevention and treatment fund which would pool
resources from rich countries to provide access to low-cost drugs for
HIV/AIDS, tuberculosis, and malaria. However, they opposed any effort
to link the endowment of such a fund to conditions such as the
surrender by developing countries of their rights under TRIPS to
utilize compulsory licensing, parallel imports, and other mechanisms
to assure sustainable access to low priced, high quality essential

The NGOs will continue working to support the development of an
effective, long-term, sustainable, global strategy and a drug
procurement and distribution system to provide affordable drugs for
people with HIV/AIDS in developing countries.

James Love.  Knowledge Ecology International
http://www.keionline.org, +1.202.332.2670, US Mobile: +1.202.361.3040,
Geneva Mobile: +41.76.413.6584, efax: +1.888.245.3140.

More information about the Ip-health mailing list